In collaboration with Allscripts and NantHealth, the Cancer Treatment Centers of America is incorporating a custom technical solution which enables a NantHealth Clinical decision support solution called eviti to gain access to clinical workflows in the electronic health record of Allscripts Sunrise. With seamless instances of integration of this particular clinical decision support solution, the Clinical Pathways program is helping to inform the cancer treatment process, without having an effect of interrupting the clinical workflow of the physician. The direct interface of the clinical operating system had been built with an input of hundreds of oncologists all throughout the nation and holds comprehensive collections of cancer care data that is evolving.
They are presenting all types of appropriate options of treatment. It is also helping to potentially eliminate guesswork by clinicians who are routinely inundated with oncology research and new data. There has been a creating of an ecosystem of treatment options that are customized to the Cancer Treatment Centers of America standards of proper care, in which patients are capable of reviewing and choosing from what is efficient and safe.
Designed and engineered with the patient as its primary focus, Clinical Pathways is integrating the latest cancer research that is available, complementary therapies and treatment regimens into the Allscripts Sunrise EHR, giving oncologists abilities of creating curated lists of care protocols at points of care. When treatment platforms are engaged, they provide: custom treatment regimens that are specific to each patient, average market cost of delivery, health and disease state comparisons between options of treatment, and more.
Cancer Treatment Centers of America is creating greater instances of transparency around care delivery and therapeutic selection, and is also assisting with improving efficiency and quality by reducing the variability that exists in care. With this particular platform of integration, the clinical teams and their patients are capable of discussing and comparing treatment regimens, which greater confidence for patients of the appropriateness of their specific diagnosis’s prescribed treatments.
For further information follow CTCA on Twitter.